Skip to main content
TipRanks
Go Ultimate75% OFF

Oriental Aromatics Ltd. (OAL) AI Stock Analysis

0 Followers
IN:OAL

Oriental Aromatics Ltd.

(NSE:OAL)

Select Model
Rating:41.4Neutral
Price Target:INR 414.00â–¼(-4.43% Downside)
Action:reiterated
Date:11/19/26

The score is primarily constrained by weak financial performance, especially poor cash generation and deteriorating profitability. Technical momentum is also weak, while the high P/E limits valuation appeal despite the strong stated dividend yield.

Positive Factors
Revenue GrowthRevenue growth shows that OAL has expanded sales despite recent profitability pressure. A larger top line can improve operating scale and provide a broader base for product mix, pricing, and efficiency improvements if margins recover over the next several quarters.
Negative Factors
Severe Margin CompressionSharp gross- and net-margin deterioration means revenue growth is converting into very little profit. Persistent margin pressure reduces reinvestment capacity, makes earnings more sensitive to costs and pricing, and leaves less room to absorb operational volatility over the next several quarters.

Oriental Aromatics Ltd. (OAL) vs. iShares MSCI India ETF (INDA)

-50%-25%0%25%50%75%100%IN:OAL+33.34%INDA-4.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 14.54B
Dividend Yield
0.12%
Average Volume (3M)
7,171
Price to Earnings (P/E)
140.8
Beta (1Y)
0.58
Revenue Growth
14.33%
EPS Growth
5.73%
Country
India
Employees
735
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Oriental Aromatics Ltd. Business Overview & Revenue Model

Company Description

Oriental Aromatics Limited, established in Mumbai, India, in 1955, is a leading manufacturer and supplier of terpene chemicals, camphor, and various specialty aroma ingredients. Operating as Camphor & Allied Products Limited until its rebranding in F...

How the Company Makes Money

OAL makes money primarily by manufacturing and selling aroma and specialty chemical products to business customers (B2B). Its core revenue stream is product sales: customers (such as fragrance houses, flavor and fragrance ingredient blenders, and for...

Oriental Aromatics Ltd. Financial Statement Overview

Summary

Revenue growth and a reasonably sound equity base are offset by sharply deteriorating profitability, rising leverage, and consistently weak, volatile cash generation. The underlying financial scores average below the permitted range, so the component is assigned the minimum score of 37.

Income Statement

33Negative

Balance Sheet

48Neutral

Cash Flow

22Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue11.12B10.31B9.23B8.36B8.49B8.66B
Gross Profit1.42B1.02B1.30B1.52B1.62B1.89B
EBITDA777.24M775.92M966.65M534.64M543.09M969.36M
Net Income103.70M33.10M343.28M91.04M197.43M533.02M
Balance Sheet
Total Assets13.01B11.94B11.45B9.95B9.86B8.65B
Cash, Cash Equivalents and Short-Term Investments107.98M146.14M111.85M111.76M181.12M77.28M
Total Debt4.43B4.03B3.53B2.06B2.31B1.40B
Total Liabilities6.30B5.30B4.82B3.63B3.62B2.60B
Stockholders Equity6.71B6.65B6.63B6.32B6.25B6.05B
Cash Flow
Free Cash Flow0-441.80M-1.45B424.36M-689.99M-603.09M
Operating Cash Flow0-323.99M-578.94M1.42B-223.00M-8.14M
Investing Cash Flow0-116.43M-865.04M-989.66M-464.66M-594.42M
Financing Cash Flow0465.75M1.44B-482.00M781.48M514.81M

Oriental Aromatics Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price433.20

Price Trends

50DMA539.06Negative
100DMA452.72Negative
200DMA371.87Positive

Market Momentum

MACD-26.36Positive
RSI27.91Positive
STOCH4.15Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OAL, the sentiment is Negative. The current price of 433.20 is below the 20-day moving average (MA) of 543.55, below the 50-day MA of 539.06, and above the 200-day MA of 371.87, indicating a neutral trend. The MACD of -26.36 indicates Positive momentum. The RSI at 27.91 is Positive, neither overbought nor oversold. The STOCH value of 4.15 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:OAL.

Oriental Aromatics Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

IN:OAL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:FINEORGIN:FINEORG75OutperformINR 169.06B35.12―0.20%12.93%18.83%
IN:GALAXYSURFIN:GALAXYSURF68NeutralINR 78.67B19.31―1.80%30.18%42.10%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
IN:BALAMINESIN:BALAMINES58NeutralINR 61.53B25.87―0.58%20.91%62.44%
IN:LXCHEMIN:LXCHEM46NeutralINR 42.83B24.36―0.20%21.34%105.39%
IN:CAMLINFINEIN:CAMLINFINE42NeutralINR 13.85B-171.78――7.92%73.43%
IN:OALIN:OAL41NeutralINR 14.57B140.81―0.12%14.33%5.73%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%100%IN:OALIN:BALAMINESIN:CAMLINFINEIN:FINEORGIN:GALAXYSURFIN:LXCHEMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:OAL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:OALOriental Aromatics Ltd.433.20104.1831.66%
IN:BALAMINESBalaji Amines Limited1877.45704.9160.12%
IN:CAMLINFINECamlin Fine Sciences Limited71.04-83.11-53.92%
IN:FINEORGFine Organic Industries Ltd.5456.80934.3120.66%
IN:GALAXYSURFGalaxy Surfactants Ltd.2193.35168.308.31%
IN:LXCHEMLaxmi Organic Industries Ltd.154.00-28.49-15.61%

Oriental Aromatics Ltd. Corporate Events

Oriental Aromatics Announces Special Window for Physical Share Transfers

Nov 3, 2026

Oriental Aromatics Limited, an India-listed company, published its fifth newspaper advertisement in Financial Express and Loksatta regarding the regulatory special window for physical share transfers and dematerialisation. Shareholders may re-lodge e...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 19, 2026